PURE Bioscience, Inc. (OTCMKTS:PURE – Get Rating) was the target of a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 16,000 shares, a growth of 3,900.0% from the February 13th total of 400 shares. Based on an average daily trading volume, of 45,800 shares, the days-to-cover ratio is currently 0.3 days.
PURE Bioscience Price Performance
Shares of PURE Bioscience stock traded down $0.02 during trading hours on Friday, reaching $0.13. The company had a trading volume of 32,900 shares, compared to its average volume of 20,827. PURE Bioscience has a one year low of $0.07 and a one year high of $0.24. The business has a fifty day simple moving average of $0.12 and a 200 day simple moving average of $0.16.
Get
PURE Bioscience alerts:
PURE Bioscience (OTCMKTS:PURE – Get Rating) last posted its quarterly earnings data on Wednesday, December 14th. The company reported ($0.01) EPS for the quarter. The firm had revenue of $0.47 million for the quarter. PURE Bioscience had a negative net margin of 206.26% and a negative return on equity of 135.85%.
Institutional Trading of PURE Bioscience
An institutional investor recently bought a new position in PURE Bioscience stock. IFG Advisory LLC acquired a new stake in shares of PURE Bioscience, Inc. (OTCMKTS:PURE – Get Rating) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 809,809 shares of the company's stock, valued at approximately $161,000. IFG Advisory LLC owned about 0.92% of PURE Bioscience as of its most recent SEC filing. Hedge funds and other institutional investors own 0.92% of the company's stock.
PURE Bioscience Company Profile
(Get Rating)
PURE Bioscience, Inc engages in the discovery, development, and commercialization of proprietary antimicrobial products for pathogen and hygienic control. It offers silver dihydrogen citrate-based disinfecting and sanitizing products. The company was founded by Michael L. Krall on August 24, 1992 and is headquartered in Rancho Cucamonga, CA.
Read More
- Get a free copy of the StockNews.com research report on PURE Bioscience (PURE)
- Can Investors Trust Consumers to Lift American Outdoor Brands?
- How to Buy High Yielding Dividend Stocks
- Oracle Has Spoken: Shares Fall 5%
- Just the Catalyst NIO Investors Needed
- FuelCell Energy Gains Traction, Shares Surge
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
